Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 19 条
  • [1] BARHAM KL, 2004, ROOKS TXB DERMATOLOG, V3, P36
  • [2] Treatment of pyoderma gangrenosum with intravenous immunoglobulin
    Cummins, D. L.
    Anhalt, G. J.
    Monahan, T.
    Meyerle, J. H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) : 1235 - 1239
  • [3] Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin
    Dirschka, T
    Kastner, U
    Behrens, S
    Altmeyer, P
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (05) : 789 - 790
  • [4] Superficial granulomatous pyoderma treated with intravenous imunoglobulin
    Dobson, CM
    Parslew, RA
    Evans, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (03) : 456 - 460
  • [5] EBRINGER A, 1969, BRIT J EXP PATHOL, V50, P559
  • [6] Leukocytapheresis treatment for pyoderma gangrenosum
    Fujimoto, E
    Fujimoto, N
    Kuroda, K
    Tajima, S
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (05) : 1090 - 1092
  • [7] EFFICACY OF HUMAN INTRAVENOUS IMMUNE GLOBULIN IN PYODERMA-GANGRENOSUM
    GUPTA, AK
    SHEAR, NH
    SAUDER, DN
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (01) : 140 - 142
  • [8] The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum
    Hagman, JH
    Carrozzo, AM
    Campione, E
    Romanelli, P
    Chimenti, S
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (01) : 19 - 22
  • [9] Intravenous immunoglobulin for pyoderma gangrenosum
    Kreuter, A.
    Reich-Schupke, S.
    Stuecker, M.
    Altmeyer, P.
    Gambichler, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (04) : 856 - 857
  • [10] PYODERMA GANGRENOSUM, ALTERED DELAYED-HYPERSENSITIVITY, AND POLYARTHRITIS
    LAZARUS, GS
    ROCKLIN, RE
    DAVID, JR
    BUISSERE.JP
    GOLDSMITH, LA
    PINALS, RS
    DRAPER, W
    [J]. ARCHIVES OF DERMATOLOGY, 1972, 105 (01) : 46 - +
12